Author profile
Editorial team for Peptide Therapy Guide.
From this author
The emergence of peptide therapeutics marks a transformative shift in the types of products being developed and manufactured in the pharmaceutical industry. Peptides, defined by the FDA as biopolymers under 40…
Read guide →Australia is well known for having many of the world's most venomous creatures, ranging from snakes, spiders, jellyfish, centipedes, fish, ticks, bees, and ants. 21 of the 25 most venomous snakes in the world …
Read guide →LL37 binds to self-DNA, which allows it to enter pDCs thus triggering the production of interferon-alpha. A peptide that acts as a natural antibiotic against invading microbes can also bind to the body’s own D…
Read guide →Oral IL-23 inhibitor improves psoriasis through 1 year Key takeaways: - JNJ-77242113 is a targeted oral peptide that inhibits the IL-23 receptor. - Patients with psoriasis showed improvement with JNJ-77242113,…
Read guide →Following a contentious advisory committee meeting and an FDA request for the withdrawal of Oncopeptides’ multiple myeloma drug Pepaxto from the U.S. market in late 2022, the other shoe has dropped. The FDA ha…
Read guide →In a recent study published in the journal Scientific Reports, researchers explore the antimicrobial and anticancer properties of bioactive peptides derived from abalone fish viscera. Study: Antimicrobial and …
Read guide →A bicyclic peptide (white) bound to serum albumin (red) through the newly developed ligand (green), floating in the bloodstream. [C. Heinis/EPFL] Peptides should make ideal drug molecules as they display high …
Read guide →Obesity startup Alveus Therapeutics launched Thursday with about $160 million in venture funding aimed at supporting testing of a drug that works similarly to a closely watched therapy being developed by Amgen…
Read guide →A client of Concept Life Sciences had discovered a series of innovative peptides with strong phenotypic potency. However, progress was hindered by a lack of target engagement data, which limited the ability to…
Read guide →What is teriparatide, and how does it work (mechanism of action)? - Teriparatide (Forteo) is a prescription medicine used to treat osteoporosis, a bone disease that over time causes bones to become fragile and…
Read guide →Generic Name: oxytocin Brand Names: Pitocin Drug Class: Oxytocic Agents What is oxytocin, and what is it used for? Oxytocin used as medication is a synthetic form of the natural human hormone oxytocin produced…
Read guide →Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) is a combination medicine approved by the FDA in 2024. Alyftrek is approved to treat people ages 6 and older who have the genetic condition called cystic fibrosi…
Read guide →Peanuts were once a snack-time staple, but these days, they are largely off-limits for a growing number of kids and adults. It’s common now not to serve certain foods at birthday parties or school to keep kids…
Read guide →Diagnosis A healthcare professional typically diagnoses Ehlers-Danlos syndrome after they learn about your health and family history and doing a physical exam. They ask about your symptoms, such as joint pain,…
Read guide →Overview Ehlers-Danlos syndrome (EDS) is a group of inherited conditions that affect the body's connective tissues. These tissues provide support and give flexibility to the skin, joints, blood vessels and org…
Read guide →Your body produces C-reactive protein, or CRP, when something is starting to become inflamed. So if a doctor finds CRP in your blood, which they can do through a test, they’ll know there’s inflammation happeni…
Read guide →Dive Brief: - Aimmune Therapeutics said Thursday the Food and Drug Administration's advisory committee on allergenic products will review its experimental peanut allergy pill in September, setting a date for a…
Read guide →Description TK2 -related mitochondrial DNA depletion syndrome, myopathic form ( TK2 -MDS) is an inherited condition that causes progressive muscle weakness (myopathy). The signs and symptoms of TK2 -MDS typica…
Read guide →Dive Brief: - Vertex Pharmaceuticals said Wednesday it will stop working on a closely watched experimental drug because of safety signals seen in a mid-stage study. - The study was testing Vertex's drug, VX-81…
Read guide →Dive Brief: - Transplant patients in the U.S. with a common infection now have a new treatment option, with this week's approval of Takeda Pharmaceutical's maribavir, which will be sold in the U.S. as Livtenci…
Read guide →